Company
United StatesCytovance Biologics Inc., Oklahoma City, OK – FDA Inspections
Inspection records and compliance data for Cytovance Biologics Inc. in Oklahoma City, Oklahoma. 4 FDA inspections on record, 3 Form 483s, last inspected June 17, 2026.
Company Profile
This profile covers Cytovance Biologics Inc. based in Oklahoma City, Oklahoma, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Unclassified
- 2
- Form 483s
- 3
- Warning letters
- 0
First inspected July 20, 2017. Last inspected June 17, 2026.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 17, 2026 | Not classified | Human Drugs | 1322570 |
| May 9, 2019 | NAI | Human Drugs · Drug Quality Assurance | 1089182 |
| April 27, 2018 | Not classified | Biologics | 1078729 |
| July 20, 2017 | VAI | Human Drugs · Drug Quality Assurance | 1026556 |
FDA documents
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Cytovance Biologics Inc.
FEI Number
3006341547
Address
800 Research Pkwy Ste 200, Oklahoma City, Oklahoma 73104, United States
Country
United States
ID: a03c370a-5e60-4617-95b1-521a1d305ac2